The title compound, [Cu 2 (C 14 H 10 Cl 2 NO 2 ) 4 (C 2 H 6 OS) 2 ], comprises a Cu II 2 core that is quadruply bridged by four carboxylate ligands with the dimethyl sulfoxide ligands binding along the CuÁ Á ÁCu axis. The four carboxylate ligands bind in a bidentate syn-syn bridging mode. Molecules reside on crystallographic inversion centres bisecting the mid-point of the CuÁ Á ÁCu axis. There are no intermolecular interactions of note.
Related literature
Cu II complexes of non-steroidal anti-inflammatory drugs (NSAIDs) show enhanced anti-inflammatory activity and reduced gastrointestinal toxicity compared with their uncomplexed parent drug, see : Weder et al. (2002) . The structure of the Cu-NSAID is likely to be an important factor for its biological activity. For example, the anti-tumor activity of the monomeric Cu II complex of aspirin ([Cu(Asp) 2 (py) 2 ]) is reportedly more effective than the dimeric [Cu 2 (Asp) 4 ] complex, see : Oberley & Buettner (1979) . It has been shown that dinuclear Cu-NSAID complexes exhibit similar biological activity to mononuclear complexes, but with higher stability (Dimiza et al., 2011) , making them relevant compounds in the treatment of tumor cell lines (Theodorou et al., 1999) . For mono-and binuclear Cu II complexes of diclofenac, see: Sayen et al. (2012) Table 1 Selected geometric parameters (Å , ). , 1997) . The former resulted in a distorted octahedral geometry, whereas the latter resulted in a binuclear copper complex where each metal centre is described as a perfect square bipyramid with a DMF oxygen occupying apical position. In order to favour the metal···metal bond, which stabilizes the complex and thus impact the biological activity, we have tried various coordinating solvents during the recrystallization.
The structure of the binuclear [bis(2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoate)bis(DMSO)copper(II)] complex (I) has been obtained. It consists of a quadruply bridged neutral molecule lying on a crystallographic centre of inversion ( Fig. 1) . Indeed, the four carboxylato moieties act as bridging ligands exhibiting a centre of symmetry midway between the two Cu atoms. The solvent used in the synthesis binds in the position trans to the Cu-Cu axis. The dimeric structure has a Cu-Cu distance of 2.6619 (12) Å, with an octahedral stereochemistry tetragonally elongated along the Cu-Cu-O solvent axis due to the Jahn-Teller effect (Table 1 ).
In the binuclear unit, the carboxylic acids are fully deprotonated to balance the charge from the Cu II ions. The stability of the structure is ensured via a network of /p···/p interactions involving the phenyl acetate rings of the diclofenac molecules. On the other hand, no intermolecular H-bonding is observed (Fig. 2 ).
The use of DMSO solvent allowed the formation of a binuclear complex with a Cu 2 metal core, which stabilizes the complex in biological media. It was shown that binuclear Cu-NSAID complexes exhibit similar biological activity as the mononuclear complex, but with a higher stability (Dimiza et al., 2011) , making them relevant compounds in the treatment of tumor cell lines (Theodorou et al., 1999 (Sheldrick, 2008) ; software used to prepare material for publication: SHELXL97 (Sheldrick, 2008) .
Figure 1
A representation of the title compound (I) with displacement ellipsoids at the 30% probability level.
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Figure 2
The π···π stacking interactions in the [Cu 2 (diclofenac) 4 (DMSO) 2 ] complex (H atoms are omitted for clarity). (5 O1D-S1D-C1D 106.71 (7) C5-C6-H6 119.9 O1D-S1D-C2D 106.52 (7) C7-C6-H6 119.9 C1D-S1D-C2D 98.13 (8) S1D-C2D-H03A 109.5 C21-O2-Cu1 120.01 (9) S1D-C2D-H03B 109.5 S1D-O1D-Cu1
133. 
